Latest filing published 14 Jul 2026 for Liminatus Pharma, Inc..
Insider track record
No signal scores available.
Valetudo Therapeutics LLC: trading record in brief
Valetudo Therapeutics LLC discloses dealings in Liminatus Pharma, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 24 June 2026 and the latest from 2 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 14 July 2026, reports a transaction in Liminatus Pharma, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Valetudo Therapeutics LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,448,926 sharesCommon Stock, par value $0.0001 per shareSEC:0001104659-26-083588:0
- 4,373,603 sharesCommon Stock, par value $0.0001 per shareSEC:0001104659-26-080806:0
2 of 2 declarations